ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0 or 2.
boolean
C1520224 (UMLS CUI [1])
Solid tumour | Estimated Glomerular Filtration Rate Level Elevated | Squamous cell carcinoma of the head and neck | Non-Small Cell Lung Carcinoma | Triple-Negative Breast Cancer Finding
Item
has a solid tumor likely to exhibit elevated levels of egfr (e.g. head and neck squamous cell carcinoma, non-small cell lung cancer, triple negative breast cancer
boolean
C0280100 (UMLS CUI [1])
C3811844 (UMLS CUI [2,1])
C0441889 (UMLS CUI [2,2])
C3163633 (UMLS CUI [2,3])
C1168401 (UMLS CUI [3])
C0007131 (UMLS CUI [4])
C2348819 (UMLS CUI [5])
Colorectal Carcinoma | Glioblastoma Multiforme
Item
,colorectal carcinoma and glioblastoma multiforme).
boolean
C0009402 (UMLS CUI [1])
C1621958 (UMLS CUI [2])
Tumor tissue sample Diagnostic archived Availability Analysis
Item
has an archived, diagnostic tumor tissue available for analysis.
boolean
C0475358 (UMLS CUI [1,1])
C0348026 (UMLS CUI [1,2])
C1548398 (UMLS CUI [1,3])
C0470187 (UMLS CUI [1,4])
C0936012 (UMLS CUI [1,5])
Hematologic function | Renal function | Cardiac function | Liver function
Item
has adequate hematologic, renal, cardiac and hepatic function.
boolean
C0221130 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0232164 (UMLS CUI [3])
C0232741 (UMLS CUI [4])
Cohort Safety Expanded | Secondary malignant neoplasm of lung | Disease Progression | Prior Chemotherapy Containing Platinum
Item
expanded safety cohort participants must have confirmed metastatic lung cancer and progressed after receiving prior platinum-containing chemotherapy.
boolean
C0599755 (UMLS CUI [1,1])
C0036043 (UMLS CUI [1,2])
C0205229 (UMLS CUI [1,3])
C0153676 (UMLS CUI [2])
C0242656 (UMLS CUI [3])
C1514457 (UMLS CUI [4,1])
C0332256 (UMLS CUI [4,2])
C0032207 (UMLS CUI [4,3])
Monoclonal Antibodies Previous As directed for Estimated Glomerular Filtration Rate
Item
previously received an egfr-directed monoclonal antibody within the past 4 weeks.
boolean
C0003250 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C1720148 (UMLS CUI [1,3])
C3811844 (UMLS CUI [1,4])
Cancer treatment Previous Causing Toxic effect | Common Terminology Criteria for Adverse Events
Item
has unresolved, clinically significant toxicities from prior anti-cancer therapy defined as > grade 1 on common terminology criteria for adverse events.
boolean
C0920425 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C0678227 (UMLS CUI [1,3])
C0600688 (UMLS CUI [1,4])
C3888020 (UMLS CUI [2])
Immunologic reaction Major Pharmacologic Substance Containing Immunoglobulin G
Item
history of major immunologic reaction to any igg containing agent.
boolean
C0301873 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C1254351 (UMLS CUI [1,3])
C0332256 (UMLS CUI [1,4])
C0020852 (UMLS CUI [1,5])
Medical condition High risk of Toxic effect
Item
any medical condition which in the opinion of the investigator places the participant at an unacceptably high risk for toxicities.
boolean
C1699700 (UMLS CUI [1,1])
C0332167 (UMLS CUI [1,2])
C0600688 (UMLS CUI [1,3])